BackALK-Abelló A/S Overview

ALK-Abelló A/S Receivables

Track ALK-Abelló A/S's receivables ($1.4B) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Receivables
$1.45B
↑ 28.51% YoYΔ $321.00M vs prior year quarter

Peer trimmed avg / median

Loading

ALK-Abelló A/S Receivables History

Loading

ALK-Abelló A/S vs. peers: Receivables Comparison

Loading

ALK-Abelló A/S Receivables Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

ALK-Abelló A/S (AKABY) FAQ

As of the most recent data (September 2026), AKABY shows a receivables of $1.4B. That compares with $1.1B in the prior-year period — up 28.5% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AKABY's receivables is now $1.4B (was $1.1B) — a 28.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether ALK-Abelló A/S is outperforming or lagging.

Tracking AKABY's receivables over time shows whether ALK-Abelló A/S is scaling, shrinking, or reshaping that part of the business. The current reading is $1.4B That compares with $1.1B in the prior-year period — up 28.5% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this receivables page, Stockcircle has ALK-Abelló A/S's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect receivables (currently $1.4B) with ownership activity and broader fundamentals.

ALK-Abelló A/S's receivables is $1.4B; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.

Questions & Answers